沉寂已久的短线"炒基"招式重出江湖！ 在上一轮"喝酒吃药"的结构性行情中，30日炒基法、7日炒基法一度在新手基民圈子里流行，即用基金 做短线，跟风追热点买爆款，赚到就卖，对一些持有7天或30天免赎回费的基金进行高抛低吸。 今年以来，科技板块结构性行情突出，细分热点层出不穷，科技、黄金等热门基金C类份额被基民热 捧。一些热门基金在三季度被申购几十亿份后又被迅速获利了结，基民"快进快出"玩得不亦乐乎。 "9月收益突破1万了！"基民小杨分享自己的基金操作方法称，"开了个'基金超市'，我买的基本上都是'7 免'(即满7天免赎回费)，哪只基金赚够5个点就跑，落袋为安。大道至简，高抛低吸，有时候难免会因为 卖掉后接着涨后悔到'拍断大腿'，但整体收益为正就好。" 像他这样快进快出的新基民不在少数，他们的目标是寻找适合做短线的基金，不占用中长期资金，像中 证A500等需要长线投资的宽基指数基金不在其考虑范围内。在PCB(印制电路板)大涨的时候，他们跟 着"吃肉"感叹幸福到"头晕目眩"，当短期风格轮动到电池时，又跟着主力加仓电池基金，甚至因场外基 金效率太低，迫不及待在尾盘时追涨场内基金。 不止新基民，一些基金博主也热衷于短线 ...

2020年至2021年"喝酒吃药"的结构性行情中，"30日炒基法"一度在基民圈子里流行，即用基金做短线， 跟风追热点买爆款，对一些持有30天免赎回费的基金进行高抛低吸。后来，这一策略进一步发展为"7日 炒基法"，紧跟市场热点，赚到就卖。 今年以来，权益市场火热，且科技结构性行情突出，细分热点层出不穷，此前沉寂已久的短线炒基战 法"重出江湖"。基民热衷于炒作科技、黄金等热门基金C类份额。三季度，多只绩优科技主题基金在净 值大涨和资金涌入的推动下，规模增长十倍以上。有趣的是，其中部分基金被申购、赎回的份额均为数 十亿级别，显示出一些基民将这些主动基金当成股票"短炒"的新趋势。 投资者晒"基金超市"收益 "9月收益突破1万了！"基民小杨分享自己的基金操作方法称，"我开了个'基金超市'，买的基本上都是'7 免'（即满7天免赎回费）基金，哪只基金赚够5个点就跑路。重点就是及时落袋为安，大道至简，高抛 低吸，有时候难免会因为'卖飞'了而拍断大腿，但整体收益为正就好。" 像小杨这样快进快出的基民不在少数，他们的目标是寻找适合做短线的基金，不占用中长期资金，像中 证A500等需要长线投资的宽基指数基金不在其考虑范围内。在PC ...

2020年至2021年"喝酒吃药"的结构性行情中，"30日炒基法"一度在基民圈子里流行，即用基金做短线， 跟风追热点买爆款，对一些持有30天免赎回费的基金进行高抛低吸。后来，这一策略进一步发展为"7日 炒基法"，紧跟市场热点，赚到就卖。 在基民晒出的持仓中，像中航机遇领航混合、永赢先进制造智选混合、中欧数字经济混合这样的绩优热 门基金时常现身。 三季度，中航机遇领航混合成为规模增长最多的主动权益基金之一，季末规模激增至132.31亿元，是二 季度末的12.47倍。这只基金由知名基金经理韩浩管理，因重仓英维克、新易盛、中际旭创、天孚通信 等热门股，截至10月29日，该基金近半年以来的回报率超过190%。三季度，该基金A类、C类份额净值 增长率分别高达88.64%、88.37%。从持仓情况来看，这只基金聚焦于具备高成长潜力的个股投资机 会，如光模块、薄膜铌酸锂、芯片级液冷等细分领域。 除了净值大涨带来的规模暴增外，中航机遇领航混合部分规模增量来自基民的踊跃申购。三季度，基金 C类份额获申购98.35亿份，但同时被赎回66.48亿份，净申购31.87亿份。 今年以来，权益市场火热，且科技结构性行情突出，细分热点层出 ...

2020年至2021年"喝酒吃药"的结构性行情中，"30日炒基法"一度在基民圈子里流行，即用基金做短线， 跟风追热点买爆款，对一些持有30天免赎回费的基金进行高抛低吸。后来，这一策略进一步发展为"7日 炒基法"，紧跟市场热点，赚到就卖。 今年以来，权益市场火热，且科技结构性行情突出，细分热点层出不穷，此前沉寂已久的短线炒基战 法"重出江湖"。基民热衷于炒作科技、黄金等热门基金C类份额。三季度，多只绩优科技主题基金在净 值大涨和资金涌入的推动下，规模增长十倍以上。有趣的是，其中部分基金被申购、赎回的份额均为数 十亿级别，显示出一些基民将这些主动基金当成股票"短炒"的新趋势。 像小杨这样快进快出的基民不在少数，他们的目标是寻找适合做短线的基金，不占用中长期资金，像中 证A500等需要长线投资的宽基指数基金不在其考虑范围内。在PCB概念大涨的时候，他们及时跟进相 关主题基金，跟着"吃肉"，感叹幸福到"头晕目眩"；当短期风格轮动到电池时，又跟着主力加仓电池主 题基金，甚至因场外基金效率太低，迫不及待在尾盘时刻追涨场内产品。 一些基金博主也热衷于短线操作。例如，在支付宝、小红书等平台粉丝超过40万的基金博主"梁带逛"， ...

Core Viewpoint - Multiple public fund institutions have announced restrictions on subscriptions for their high-performing products, reflecting a shift from scale-oriented strategies to investor return-oriented strategies in the industry [1][9]. Group 1: Fund Performance and Restrictions - As of September 4, 2023, Yongying Technology Smart Mixed Fund has achieved a year-to-date return of 161.37%, making it the top-performing fund in the market [2]. - Other funds, such as the China Europe Digital Economy Mixed Fund, have also seen significant performance, with a year-to-date return of 103.75% [2]. - Fund companies like Zhongou Fund, Yifangda Fund, and Southern Fund have implemented subscription restrictions on several products that have returned over 100% this year [1]. Group 2: Reasons for Subscription Restrictions - Yongying Fund stated that the restrictions aim to protect existing investors by guiding rational decision-making and controlling fund size growth to maintain investment strategy stability [4][5]. - Rapid growth in fund size can complicate asset allocation and dilute returns for existing investors, especially in a market with scarce quality assets [5]. - Fund companies are also responding to potential market risks by controlling inflows during periods of high volatility or elevated valuations [6]. Group 3: Market Trends and Investor Guidance - Sectors such as innovative pharmaceuticals, technology, and small-cap growth stocks are experiencing significant inflows, leading to potential asset price inflation and increased risks of market corrections [7]. - Investors are advised to focus on long-term investment logic rather than short-term subscription behaviors, as restrictions do not indicate issues with the funds themselves [8]. - Diversifying investments into other complementary funds is recommended for investors who are unable to subscribe to restricted products [8]. Group 4: Industry Implications - The current wave of fund subscription restrictions can be seen as a microcosm of the industry's commitment to high-quality development, as outlined in the CSRC's action plan for promoting high-quality development in public funds [9]. - The proactive subscription limits by high-performing products signal a departure from scale-driven approaches, prioritizing the interests of existing investors and returning to the core of asset management [9].

Group 1 - The A-share market is showing significant strength in 2025, with the Shanghai Composite Index reaching a nearly ten-year high, benefiting equity funds significantly [2] - As of the end of July, the public fund management scale has surpassed 35 trillion yuan, indicating robust growth in the fund industry [2] - Among public fund companies, 19 reported net profits exceeding 200 million yuan, with only a few, including GF Fund, China Europe Fund, and Industrial Bank Fund, achieving net profit growth over 40% [2] Group 2 - A group of outstanding fund managers has provided diverse investment solutions during the market's upward trend, catering to different investor preferences [2][3] - Notable fund managers include Ma Xiang from Huatai-PB, Lan Xiaokang from China Europe Fund, and Wang Guizhong from Harvest Fund, all demonstrating strong research capabilities in 2025's structural market [2] Group 3 - The technology sector has taken over from innovative pharmaceuticals, becoming the core focus of the market due to its high growth and elasticity [5] - The launch of DeepSeek has ignited a global AI trend, boosting related sectors such as semiconductors and cloud computing, with fund managers strategically positioning themselves in these areas [5] Group 4 - Several fund managers have achieved significant returns through precise operations in technology stocks, with notable stock performances including Xinyi Sheng (up 335.58%) and Zhongji Xuchuang (up 212.17%) [6] - Ma Xiang's Huatai-PB Technology Innovation Mixed Fund has seen a return of over 240%, while Lan Xiaokang's China Europe Dividend Enjoyment Fund has achieved a return of 50.73% [6] Group 5 - The A-share market is experiencing structural differentiation, with innovative pharmaceuticals and technology stocks as the main players, while traditional value investments face challenges [8] - Lan Xiaokang's value-balanced strategy has yielded impressive results, with his fund outperforming the market and becoming a benchmark for value investment in a structured market [8] Group 6 - Lan Xiaokang's investment approach combines top-down and bottom-up perspectives, allowing for flexible asset allocation based on macroeconomic analysis [8] - His focus on cyclical and high-end manufacturing sectors has demonstrated market insight and adaptability in asset allocation strategies [8] Group 7 - The performance of Hong Kong insurance companies has improved significantly post-trade war, with Lan Xiaokang's dividend strategy showing strong results, particularly in the financial sector [9] - His analysis of anti-involution policies suggests that leading cyclical companies will see profit recovery, presenting new high-dividend asset opportunities [9]

Core Viewpoint - The recent surge in market activity has led several high-performing funds to implement "purchase limits" to protect existing investors' returns and transition from a scale-oriented approach to a return-oriented strategy [1][4]. Group 1: Fund Purchase Limits - Multiple high-performing funds have recently announced purchase limits, including Caizhong Securities' digital economy mixed fund, which has a return rate of 56.37% year-to-date as of August 18 [2]. - Longcheng Pharmaceutical Industry Selected Mixed Fund and Jianxin Flexible Allocation Mixed Fund have also suspended large purchases, with return rates of 135.09% and 49.74% respectively [2]. - The招商成长量化选股 fund has limited single or cumulative applications to 20,000 yuan, with a year-to-date return of 29.55% [3]. Group 2: Reasons for Purchase Limits - Fund managers indicate that limiting purchases is primarily to protect performance, as new inflows at high net asset values can dilute returns and lead to inefficient cash management [4]. - Controlling fund size is crucial to avoid operational constraints on portfolio adjustments, especially when the fund size exceeds the manager's capability [4]. - The current trend reflects a shift from a scale-driven approach to one focused on investor returns, as evidenced by the limited purchases of high-performing products [4]. Group 3: Focus on Popular Sectors - The funds implementing purchase limits are primarily concentrated in popular sectors such as innovative pharmaceuticals, technology, and military industries, which are currently crowded trading areas [5]. - Fund companies are exploring other niche sectors and offering "fixed income plus" and FOF products to provide investors with a balanced selection [6]. - There is a growing interest in FOF products, with over 90% achieving positive returns this year, making them a new direction for asset allocation [6].

Core Viewpoint - The recent trend of high-performing funds implementing "purchase limits" reflects a shift from scale-oriented strategies to investor return-oriented strategies, aimed at protecting existing fund holders' interests amidst a hot market [1][3]. Group 1: Fund Purchase Limits - Several high-performing funds have recently announced limits on large purchases, including the Caizhong Securities Asset Management's Digital Economy Mixed Fund, which has a return rate of 56.37% year-to-date as of August 18 [1]. - The Great Wall Pharmaceutical Industry Selected Mixed Fund and the CCB Flexible Allocation Mixed Fund have also set purchase limits, with year-to-date return rates of 135.09% and 49.74%, respectively [2]. - The招商成长量化选股 fund has implemented its second purchase limit this year, with a return rate of 29.55% as of August 18 [2]. Group 2: Reasons for Purchase Limits - Fund managers indicate that limiting purchases is necessary to protect performance, as large inflows at high net asset values can dilute returns and lead to inefficient cash management [2][3]. - Controlling fund size is crucial to avoid operational constraints on portfolio adjustments, especially when the fund size exceeds the manager's capability, which could lead to significant net asset value fluctuations [3]. Group 3: Market Focus and Alternatives - The limited funds primarily focus on popular sectors such as innovative pharmaceuticals, technology, and military industries, which are currently crowded, suggesting that now may not be the optimal time to invest [3]. - Fund companies are exploring other niche sectors and offering products like "fixed income plus" and FOFs to provide investors with a balanced selection [3][4]. - There is a growing interest in "fixed income plus" products and FOFs, with over 90% of FOFs achieving positive returns this year, making them an attractive option for investors seeking stable returns [4].

Core Viewpoint - The recent trend of high-performing funds implementing purchase limits reflects a shift from a scale-oriented approach to a focus on investor returns, aiming to optimize long-term investment performance while protecting existing investors' interests [1][4][6]. Group 1: Fund Purchase Limits - Multiple high-performing funds have announced purchase limits, including the招商成长量化选股, which reduced its maximum single purchase amount from 200,000 to 20,000 yuan within a month due to high demand, achieving a year-to-date return of 26.16% as of August 14 [2]. - 中欧数字经济混合 and 长信国防军工量化混合 also implemented limits, with year-to-date returns of 75.44% and 37% respectively, indicating a broader trend among funds to restrict large inflows [3]. - As of mid-August, 31 funds with over 50% year-to-date returns were fully closed to new investments, while 69 funds had suspended large purchases [3]. Group 2: Reasons for Purchase Limits - Industry experts suggest that the limits are primarily to protect existing investors from the adverse effects of new capital inflows, which could force fund managers to invest at high net asset values, potentially diluting returns [4][5]. - The shift in strategy is also influenced by the capacity constraints of small-cap funds, which can suffer from increased trading costs and reduced excess returns when inflows exceed optimal levels [4][5]. Group 3: Industry Transformation - The trend of limiting purchases signals a transformation in the fund industry from a focus on scale to prioritizing investor returns, as emphasized by recent regulatory guidance aimed at promoting long-term stable returns for investors [6]. - Fund companies are increasingly recognizing the importance of maintaining performance stability and strategy effectiveness, which can be compromised by rapid growth in fund size [5][6].

Core Viewpoint - The article discusses the recent trend of high-performing funds implementing purchase restrictions despite a strong market, indicating a shift from a scale-oriented approach to a focus on investor returns [2][5][7]. Group 1: Market Performance and Fund Trends - The market has been performing well, with major indices strengthening and sectors like artificial intelligence, innovative pharmaceuticals, military industry, and financial technology driving fund net values up [1]. - Several high-performing funds have announced purchase restrictions, including quantitative funds and actively managed equity funds focused on hot sectors like AI and innovative pharmaceuticals [2][3]. Group 2: Reasons for Purchase Restrictions - Fund companies are increasingly opting for purchase limits to mitigate the impact of scale on performance, prioritizing long-term investment results over short-term capital inflows [2][5]. - The trend reflects a transition in the fund industry from a scale-driven model to one that emphasizes investor returns, aiming to protect existing investors from the adverse effects of new capital inflows at high net asset values [5][6]. Group 3: Specific Fund Actions - On August 14, 2023, 招商基金 announced restrictions on large purchases for its 招商成长量化选股 fund, reducing the limit from 200,000 to 20,000 yuan, highlighting the strong demand for the fund, which had a year-to-date return of 26.16% [3]. - Other funds, such as 中欧数字经济混合 and 长信国防军工量化混合, also implemented similar restrictions, with year-to-date returns of 75.44% and 37%, respectively [4]. Group 4: Industry Shift and Regulatory Support - The shift towards limiting fund sizes is supported by regulatory guidance, such as the directive from the Central Financial Office and the CSRC, which encourages fund companies to focus on long-term investor returns rather than just scale [7]. - The article emphasizes that the recent purchase restrictions signal a significant change in the operational philosophy of fund companies, moving towards a model centered on investor interests [7].